BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23518008)

  • 1. Non linear mixed effects analysis in PET PK-receptor occupancy studies.
    Berges A; Cunningham VJ; Gunn RN; Zamuner S
    Neuroimage; 2013 Aug; 76():155-66. PubMed ID: 23518008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic modelling using basis functions derived from two-tissue compartmental models with a plasma input function: general principle and application to [18F]fluorodeoxyglucose positron emission tomography.
    Hong YT; Fryer TD
    Neuroimage; 2010 May; 51(1):164-72. PubMed ID: 20156574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of parametric images using mixed-effects models: a feasibility study.
    Huang HM; Shih YY; Lin C
    NMR Biomed; 2016 Mar; 29(3):239-47. PubMed ID: 26915793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear Mixed-Effects Models for PET Data.
    Chen Y; Goldsmith J; Ogden RT
    IEEE Trans Biomed Eng; 2019 Mar; 66(3):881-891. PubMed ID: 30072311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-linear mixed effect modelling approach for metabolite correction of the arterial input function in PET studies.
    Veronese M; Gunn RN; Zamuner S; Bertoldo A
    Neuroimage; 2013 Feb; 66():611-22. PubMed ID: 23108277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor Antagonist.
    Xu Y; Miao X; Ravenstijn P; Hijzen A; Schmidt ME; Nandy P; Zhou H
    Clin Transl Sci; 2020 Mar; 13(2):309-317. PubMed ID: 31642608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteers.
    Kågedal M; Cselényi Z; Nyberg S; Jönsson S; Raboisson P; Stenkrona P; Hooker AC; Karlsson MO
    Neuroimage; 2012 Jul; 61(4):849-56. PubMed ID: 22425672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of kinetic parameter estimation methods in dynamic FDG-PET studies.
    Dai X; Chen Z; Tian J
    Nucl Med Commun; 2011 Jan; 32(1):4-16. PubMed ID: 21166088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An input function estimation method for FDG-PET human brain studies.
    Guo H; Renaut RA; Chen K
    Nucl Med Biol; 2007 Jul; 34(5):483-92. PubMed ID: 17591548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpectedly high affinity of a novel histamine H(3) receptor antagonist, GSK239512, in vivo in human brain, determined using PET.
    Ashworth S; Berges A; Rabiner EA; Wilson AA; Comley RA; Lai RY; Boardley R; Searle G; Gunn RN; Laruelle M; Cunningham VJ
    Br J Pharmacol; 2014 Mar; 171(5):1241-9. PubMed ID: 24670146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear Mixed-Effects Modeling Approach for Simplified Reference Tissue Model.
    Shieh D; Matheson GJ; Ogden RT
    IEEE Trans Biomed Eng; 2024 Apr; 71(4):1191-1196. PubMed ID: 37930902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted maximum likelihood estimation of PET neuroreceptor occupancy in the absence of a reference region.
    Radua J; Bullich S; Lopez N; Catafau AM
    Med Phys; 2011 May; 38(5):2558-62. PubMed ID: 21776791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct reconstruction of kinetic parameter images from dynamic PET data.
    Kamasak ME; Bouman CA; Morris ED; Sauer K
    IEEE Trans Med Imaging; 2005 May; 24(5):636-50. PubMed ID: 15889551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A data driven method for estimation of B(avail) and appK(D) using a single injection protocol with [¹¹C]raclopride in the mouse.
    Wimberley CJ; Fischer K; Reilhac A; Pichler BJ; Gregoire MC
    Neuroimage; 2014 Oct; 99():365-76. PubMed ID: 24862069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - estimating occupancy in the absence of a reference region.
    Kågedal M; Cselényi Z; Nyberg S; Raboisson P; Ståhle L; Stenkrona P; Varnäs K; Halldin C; Hooker AC; Karlsson MO
    Neuroimage; 2013 Nov; 82():160-9. PubMed ID: 23668965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Likelihood estimation of drug occupancy for brain PET studies.
    Schain M; Zanderigo F; Todd Ogden R
    Neuroimage; 2018 Sep; 178():255-265. PubMed ID: 29753104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of scatter correction on D2 receptor occupancy measurements using 123I-IBZM SPECT: comparison to 11C-Raclopride PET.
    Bullich S; Cot A; Gallego J; Gunn RN; Suárez M; Pavía J; Ros D; Laruelle M; Catafau AM
    Neuroimage; 2010 May; 50(4):1511-8. PubMed ID: 20083205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
    Panhard X; Mentré F
    Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic nonlinear mixed effects: a metformin case study.
    Matzuka B; Chittenden J; Monteleone J; Tran H
    J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):85-98. PubMed ID: 26585899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET parametric imaging improved by global-two-stage method.
    Tomasi G; Bertoldo A; Cobelli C
    Ann Biomed Eng; 2009 Feb; 37(2):419-27. PubMed ID: 19082895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.